The Los Angeles Post
U.S. World Business Lifestyle
Today: April 03, 2025
Today: April 03, 2025

Moderna co-founder Robert Langer to step down from vaccine maker's board

A sign marks the headquarters of Moderna in Cambridge
July 23, 2024
Reuters - Reuters

(Reuters) - Robert Langer, co-founder and a key figure behind Moderna's scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday.

WHY IT MATTERS

Langer played a crucial role in the development of Moderna's messenger RNA COVID vaccine, which is the biotech's only commercial product.

Moderna said it expects to focus recruitment efforts on individuals with scientific and innovation experience.

CONTEXT

Langer is one of the nine Institute Professors - the highest honor awarded to a faculty member - at the Massachusetts Institute of Technology. He was the chairman of the U.S. Food and Drug Administration and is considered the most cited academician in history.

He heads the Langer Laboratory that focuses on studying the delivery and mechanism of drugs based on genetically engineered proteins, DNA and RNA.

Additionally, Moderna said director Stephen Berenson, who has been on the board since 2017, will also step down. David Rubenstein, co-founder and co-chairman of the Carlyle Group, will replace him.

KEY QUOTES

"After many years of service as a co-founder and member of Moderna's Board of Directors, I have decided that now is the right time for me to step down," Langer said.

"As one of Moderna's co-founders, Bob (Robert) is one of the visionaries responsible for making mRNA medicines a reality, and his insights have enabled the company to positively impact hundreds of millions of lives," Moderna's chairman and co-founder Noubar Afeyan said.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur)

Related Articles

Just like AI, Chinaโ€™s biotech is disrupting the world. Is the US ready? Scientists have identified a new coronavirus in bats, but itโ€™s not a public health threat China says rising food demand requires production boost Novartis buys Blackstone's Anthos for up to $3.1 billion
Share This

Popular

Business|Economy|Political|US

Hear Trump break down tariffs on various countries

Hear Trump break down tariffs on various countries
Business|Economy|US

Fewer Americans file for jobless benefits last week as labor market continues to show strength

Fewer Americans file for jobless benefits last week as labor market continues to show strength
Business|Crime|Europe|Political

Portuguese police raid public offices, including central bank, in IT-related probe

Portuguese police raid public offices, including central bank, in IT-related probe
Business|Economy|Finance|Food|Stock Markets|US

Conagra Brands misses quarterly sales estimate on supply constraints

Conagra Brands misses quarterly sales estimate on supply constraints

Health

Economy|Health|MidEast|Political|World

Hundreds of thousands flee as Israel seizes Rafah in new Gaza 'security zone'

Hundreds of thousands flee as Israel seizes Rafah in new Gaza 'security zone'
Europe|Health|Political|World

Russia bans Elton John AIDS Foundation to defend 'spiritual and moral values'

Russia bans Elton John AIDS Foundation to defend 'spiritual and moral values'
Health|Sports|US

Philadelphia 76ers star Joel Embiid to undergo arthroscopic knee surgery

Philadelphia 76ers star Joel Embiid to undergo arthroscopic knee surgery
Asia|Environment|Health|Political|World

Myanmar earthquake death toll rises to 3,085 as more bodies found

Myanmar earthquake death toll rises to 3,085 as more bodies found

Access this article for free.

Already have an account? Sign In